Chester Wong is Vice President, Head of Business Development at Cartography Biosciences. He is responsible for creating key relationships to support the company’s mission and advance its pipeline of next-generation cancer immunotherapies. Prior to Cartography, he was a Director of Business Development at Amgen where he led the execution of numerous transactions. He holds a master’s degree in Bioscience from Keck Graduate Institute and a bachelor’s degree in Molecular Cell Biology from the University of California, Berkeley. In his spare time, Chester enjoys traveling to explore global cuisines and dialing in his espresso machine in search of the perfect shot.
Recent Posts
- Cartography Biosciences Advances Strategic Oncology Collaboration with Gilead’s First Option Target Exercise
- Cartography Biosciences Doses First Patient in Phase 1 Trial of CBI-1214, a Highly Specific T-Cell Engager for the Treatment of Colorectal Cancer
- Cartography Biosciences and Pfizer to Collaborate on the Discovery of Tumor-Selective Antigens
- Cartography Receives FDA Investigational New Drug (IND) Approval and Fast Track Designation for Lead Program CBI-1214 for Colorectal Cancer
- Cartography Secures $67 Million Series B Financing to Advance Differentiated Oncology Pipeline of Antibody-Based Therapies into the Clinic
Recent Comments
No comments to show.